BA
AVNS

Bivin & Associates’s Avanos Medical AVNS Stock Holding History

Bivin & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$0 Hold
15
– – ﹤0.01% 325
2022
Q1 		$1K Hold
15
– – ﹤0.01% 274
2021
Q4 		$1K Buy
+15
New +$485 ﹤0.01% 281

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Bivin & Associates's AVNS Position: Q2 2022 in Review

Bivin & Associates held its Avanos Medical (AVNS) position steady in Q2 2022 at 15 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #325.

Bivin & Associates first reported a position in AVNS in Q4 2021 and has held it in 3 quarters since. The position peaked at $1K in Q1 2022. 287 funds tracked by Wall St. Rank hold AVNS as of Q2 2022.

  • Bivin & Associates held 15 shares of Avanos Medical worth $0 as of Q2 2022.
  • Bivin & Associates left its Avanos Medical share count unchanged in Q2 2022.
  • Avanos Medical made up ﹤0.01% of Bivin & Associates's portfolio in Q2 2022, its #325 holding.
  • Bivin & Associates first reported a position in Avanos Medical in Q4 2021 and has held it in 3 quarters since.
  • Bivin & Associates's Avanos Medical position peaked at $1K in Q1 2022.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.